Clinical Trials Browser

Phase 1/2 × onapristone × Gynecologic × Clear all

NCT02052128 2015-06-24

Phase 1-2 Study of Onapristone in Patients With Progesterone Receptor Expressing Cancers

Phase 1/2 Unknown

BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms